Health care pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 health care pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- PLN 20.14T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | PLN 40.9B | PLN 270.29 | 1.32% up | 117% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | PLN 33.1B | PLN 477.57 | 0.56% down | 18% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | PLN 19.6B | PLN 347.58 | 2.58% up | 108% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | PLN 33.7B | PLN 515.86 | 0.55% up | 51% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | PLN 36.4B | PLN 1,302.61 | 5.79% up | 86% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | PLN 29.4B | PLN 210.70 | 1.76% up | 19% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | PLN 18.6B | PLN 111.84 | 1.20% up | 63% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | PLN 23.8B | PLN 1,191.69 | 1.12% down | 50% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | PLN 38.6B | PLN 406.16 | 0.78% down | 332% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | PLN 31.4B | PLN 186.92 | 1.11% down | 66% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | PLN 18.3B | PLN 167.23 | 0.19% up | 86% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | PLN 62.4B | PLN 320.50 | 1.83% up | 21% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | PLN 20.5B | PLN 58.42 | 5.23% up | 395% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | PLN 19.9B | PLN 114.36 | 1.92% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | PLN 24.6B | PLN 377.23 | 1.09% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | PLN 19.7B | PLN 204.96 | 1.11% up | 45% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | PLN 27.8B | PLN 409.18 | 5.93% up | 255% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | PLN 20.3B | PLN 243.12 | 0.05% up | 21% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | PLN 38B | PLN 1,634.23 | 1.75% up | 27% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | PLN 62.8B | PLN 978.90 | 2.07% down | 41% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | PLN 29.6B | PLN 270.36 | 1.15% down | 10% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | PLN 25.1B | PLN 177.72 | 2.18% up | 13% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | PLN 21.8B | PLN 515.70 | 2.37% up | 231% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | PLN 49.7B | PLN 256.40 | 3.45% up | 17% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | PLN 16.1B | PLN 117.71 | 0.19% up | 168% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | PLN 54B | PLN 108.03 | 0.28% up | 26% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | PLN 113.3B | PLN 516.54 | 6.87% up | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | PLN 115.6B | PLN 159.53 | 2.09% up | 91% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | PLN 28.8B | PLN 547.55 | 1.28% up | 6% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | PLN 12.5B | PLN 64.45 | 1.69% down | 41% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | PLN 30.1B | PLN 382.84 | 0.17% down | 129% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | PLN 35.1B | PLN 43.90 | 3.62% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | PLN 29.9B | PLN 341.77 | 1.05% up | 32% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | PLN 71.6B | PLN 1,092.05 | 0.13% up | 29% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | PLN 97.9B | PLN 2,299.69 | 1.27% down | 22% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | PLN 134.7B | PLN 331.60 | 3.95% down | 26% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | PLN 80.9B | PLN 604.36 | 0.26% up | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | PLN 25.4B | PLN 625.72 | 0.73% down | 43% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | PLN 30.4B | PLN 87.19 | 1.23% down | 90% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | PLN 92.2B | PLN 80.45 | 1.68% down | 99% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | PLN 49.9B | PLN 59.87 | 0.93% down | 8% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | PLN 191.1B | PLN 163.76 | 3.88% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | PLN 632.4B | PLN 110.95 | 2.00% down | 15% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | PLN 481.9B | PLN 235.76 | 1.89% down | 30% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | PLN 158.3B | PLN 275.32 | 0.63% down | 79% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | PLN 387.6B | PLN 3,747.05 | 1.78% down | 28% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | PLN 545.6B | PLN 2,151.83 | 0.58% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | PLN 129.9B | PLN 210.64 | 2.43% up | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | PLN 185B | PLN 1,619.61 | 0.54% down | 16% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | PLN 732.3B | PLN 422.80 | 0.30% up | 16% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | PLN 1.34T | PLN 543.75 | 2.18% down | 45% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | PLN 2.02T | PLN 1,140.49 | 1.16% down | 25% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | PLN 23B | PLN 33.75 | 1.24% down | 0% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | PLN 697.2B | PLN 158.19 | 0.56% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | PLN 4.91T | PLN 5,515.33 | 1.14% down | 33% up | ||
| 56 | GSKGSK · Health Care | 0.81% | PLN 387B | PLN 193.05 | 1.50% down | 5% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | PLN 2.59T | PLN 1,075.85 | 2.21% down | 34% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | PLN 439.6B | PLN 183.09 | 3.69% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | PLN 1.15T | PLN 610.91 | 2.44% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | PLN 1.1T | PLN 708.91 | 1.71% down | 1% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | PLN 276.4B | PLN 86.50 | 0.80% up | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0346 PLN).
Questions and answers
Which health care pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 health care pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by short interest have a combined market value of PLN 20.14T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care pharmaceutical companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.